Urban R J, Garmey J C, Shupnik M A, Veldhuis J D
Department of Internal Medicine, University of Virginia Health Sciences Center, Charlottesville 22908.
Endocrinology. 1990 Nov;127(5):2481-8. doi: 10.1210/endo-127-5-2481.
Insulin-like growth factor type I (IGF-I) is an important intraovarian peptide that stimulates granulosa cell steroidogenesis during follicular development. The cytochrome P450 cholesterol side-chain cleavage enzyme (P450scc) that converts cholesterol to pregnenolone is the rate-limiting step in progesterone biosynthesis. Since treatment of primary cultures of immature porcine granulosa cells with IGF-I will increase progesterone production as well as the synthesis of immunoprecipitable P450scc enzyme, we examined possible molecular mechanisms subserving these inductive effects of IGF-I. To this end, cultures of porcine granulosa cells were maintained in serum-free medium with or without IGF-I under various treatment paradigms. Cellular concentrations of specific P450scc mRNA were measured by Northern blot hybridization using a 32P-labeled 1-kilobase porcine cDNA clone. Northern blot autoradiogram densitometry data were normalized with a constitutively expressed 1.2-kilobase chicken glyceraldehyde-3-phosphate dehydrogenase cDNA clone. Steroidogenesis was monitored by measuring concomitant progesterone accumulation in the culture medium. Treatment with pure recombinant human IGF-I (100 ng/ml) significantly increased P450scc mRNA concentrations after 18 h, and maximal stimulation (10- to 20-fold) occurred by 48 h for both P450scc mRNA and progesterone accumulation. The IGF-I dose-response curve studied at 48 h showed a significant increase in P450scc mRNA levels at a minimal IGF-I concentration of 1 ng/ml (although progesterone production was not increased). Treatment with equimolar concentrations of epidermal growth factor, IGF-I, or insulin significantly increased P450scc mRNA concentrations, whereas fibroblast growth factor did not. To examine possible mechanisms underlying stimulation of P450scc by IGF-I, immature granulosa cells were treated with aminoglutethimide (a P450scc enzyme inhibitor), low density lipoprotein (to increase cholesterol delivery to granulosa cells), or estradiol in the presence or absence of IGF-I. Aminoglutethimide had no effect, alone or with IGF-I, on P450scc mRNA concentrations, but suppressed progesterone production. Low density lipoprotein alone also did not stimulate P450scc mRNA levels and only slightly increased progesterone accumulation, but acted synergistically with IGF-I to augment P450scc mRNA concentrations and progesterone accumulation. Estradiol alone did not stimulate P450scc mRNA concentrations, but did significantly increase progesterone production. Estradiol cotreatment with IGF-I synergistically enhanced progesterone production, but did not alter IGF-I-stimulated P450scc mRNA concentrations.(ABSTRACT TRUNCATED AT 400 WORDS)
胰岛素样生长因子I型(IGF-I)是一种重要的卵巢内肽,在卵泡发育过程中刺激颗粒细胞类固醇生成。将胆固醇转化为孕烯醇酮的细胞色素P450胆固醇侧链裂解酶(P450scc)是孕酮生物合成中的限速步骤。由于用IGF-I处理未成熟猪颗粒细胞的原代培养物会增加孕酮产量以及可免疫沉淀的P450scc酶的合成,我们研究了介导IGF-I这些诱导作用的可能分子机制。为此,在各种处理模式下,将猪颗粒细胞培养物置于含或不含IGF-I的无血清培养基中。使用32P标记的1千碱基猪cDNA克隆通过Northern印迹杂交测量特异性P450scc mRNA的细胞浓度。Northern印迹放射自显影片密度测定数据用组成性表达的1.2千碱基鸡甘油醛-3-磷酸脱氢酶cDNA克隆进行标准化。通过测量培养基中伴随的孕酮积累来监测类固醇生成。用纯重组人IGF-I(100 ng/ml)处理18小时后,P450scc mRNA浓度显著增加,48小时时P450scc mRNA和孕酮积累均出现最大刺激(10至20倍)。在48小时研究的IGF-I剂量反应曲线显示,在最低IGF-I浓度为1 ng/ml时,P450scc mRNA水平显著增加(尽管孕酮产量未增加)。用等摩尔浓度的表皮生长因子、IGF-I或胰岛素处理显著增加了P450scc mRNA浓度,而成纤维细胞生长因子则没有。为了研究IGF-I刺激P450scc的可能机制,在有或没有IGF-I的情况下,用氨鲁米特(一种P450scc酶抑制剂)、低密度脂蛋白(增加胆固醇向颗粒细胞的递送)或雌二醇处理未成熟颗粒细胞。氨鲁米特单独或与IGF-I一起对P450scc mRNA浓度没有影响,但抑制了孕酮生成。单独的低密度脂蛋白也不刺激P450scc mRNA水平,仅略微增加孕酮积累,但与IGF-I协同作用以增加P450scc mRNA浓度和孕酮积累。单独的雌二醇不刺激P450scc mRNA浓度,但显著增加孕酮生成。雌二醇与IGF-I共同处理协同增强了孕酮生成,但不改变IGF-I刺激的P450scc mRNA浓度。(摘要截断于400字)